Blood tests fail to distinguish causes of aseptic knee revision surgery

When a total knee replacement fails and needs to be revised, surgeons face a diagnostic puzzle: the joint can fail for many different reasons, and the blood tests and joint fluid analyses that work well for ruling out infection turn out to be surprisingly poor at telling those reasons apart. A new retrospective study from a single academic hospital now confirms this limitation in detail, while also flagging one intriguing exception. Among 156 patients who underwent aseptic revision total knee arthroplasty between 2012 and 2023, the standard systemic inflammatory markers erythrocyte sedimentation rate and C-reactive protein showed no significant independent association with the underlying cause of failure. Only a small subgroup of patients revised for polyethylene liner wear displayed a distinctive synovial fluid signature, dominated by monocytes and depleted of lymphocytes, a pattern the authors themselves describe as exploratory because it rested on just four patients.

The study, published in Archives of Orthopaedic and Trauma Surgery, was designed to fill a genuine gap. Diagnostic criteria for periprosthetic joint infection have been standardized through successive consensus guidelines, including the Musculoskeletal Infection Society criteria of 2011, the Infectious Diseases Society of America recommendations of 2013, the International Consensus Meeting criteria of 2013 and their 2018 update, and the European Bone and Joint Infection Society criteria of 2021. These frameworks rely heavily on serum ESR and CRP together with synovial white blood cell counts. Aseptic causes of revision, by contrast, lack equivalent diagnostic tools. Problems such as arthrofibrosis, aseptic loosening, component malposition, instability and liner wear often produce subtle radiographic changes until advanced disease generates significant pain or mechanical failure, leaving clinicians with little objective guidance on the mechanism of failure before surgery.

The research team, led by Farouk Khury and senior author Ran Schwarzkopf, retrospectively reviewed every patient who underwent aseptic revision knee replacement at their urban, high-volume academic institution during a twelve-year window. To enter the analysis, patients needed complete serum inflammatory markers and synovial fluid differential counts obtained within three months before the revision, along with negative preoperative or intraoperative bacterial cultures. Infection was excluded rigorously using the 2018 International Consensus Meeting criteria, with any patient scoring six or higher removed from the cohort. The initial query identified 1,548 patients, but the vast majority, 1,273, lacked synovial fluid aspirations or usable results in the electronic medical record. Fifty-eight patients were excluded for periprosthetic fracture, forty-seven for extensor mechanism disruption, nine for synovial fluid findings indicative of infection, and five for wound complications or surgical site infection, leaving the final cohort of 156.

That cohort was stratified into five aseptic etiologies. Aseptic loosening dominated at 50.6 percent of cases, followed by instability at 28.2 percent, arthrofibrosis at 16.7 percent, liner wear at 2.6 percent and component malposition at 1.9 percent. Patients had a mean age of 64.2 years and a mean body mass index of 34.1 kilograms per square meter, and most were women. Revisions occurred an average of 6.4 years after the primary arthroplasty. The researchers acknowledged that the severe imbalance between groups, with 79 aseptic loosening cases against only 4 tibial liner wear cases and 3 component malposition cases, substantially limits the statistical validity of pairwise comparisons and renders findings within those small subgroups exploratory.

The serological results were unambiguous. In unadjusted analyses, mean ESR values actually differed across the diagnostic groups, with instability showing the highest mean at 50.3 millimeters per hour and component malposition the lowest at 19.7 millimeters per hour, and unadjusted ESR values for instability, aseptic loosening and arthrofibrosis exceeded thresholds sometimes cited in the literature for separating septic from aseptic loosening. But once the team applied a multivariate general linear model adjusting for age, sex, body mass index, smoking history and American Society of Anesthesiologists physical status score, all of that apparent variance evaporated. The underlying revision indication was not a significant independent predictor of elevated ESR, with a P value of 0.661, or of elevated CRP, with a P value of 0.947. Because ESR and CRP are highly sensitive but inherently nonspecific acute-phase reactants, the authors argue, their systemic elevation is easily confounded by patient-specific comorbidities and cannot isolate localized mechanical modes of failure.

The synovial fluid analysis told a similar story for most measures. Welch’s analysis of variance found no significant differences across the five indication groups for synovial white blood cell counts, red blood cell counts, polymorphonuclear cell proportions, white-cell-to-red-cell ratios or polymorphonuclear-to-lymphocyte ratios. This finding adds nuance to a divided literature. Earlier work by Chalmers and colleagues reported that aseptic loosening yielded significantly higher synovial white cell counts, averaging 947 cells per microliter, compared with stiffness or component malposition, while a 2024 study by Hubert and colleagues found no difference in synovial cell counts between any aseptic indications. The raw mean for aseptic loosening in the new cohort, 1,204 cells per microliter, aligns more closely with the latter interpretation. The authors also note that automated cell counting systems can artificially inflate white cell counts in the presence of metallosis and liner wear, partly because polymeric debris can be conflated with nucleated cells, which helps explain the lack of consensus across prior studies.

Where the study broke new ground was in the cellular differential. Significant differences emerged in the percentage of synovial monocytes, with a P value below 0.001 and a medium effect size corresponding to Cohen’s f of 0.29, and in the percentage of lymphocytes, with a P value of 0.010. The polymorphonuclear-to-monocyte and lymphocyte-to-monocyte ratios also differed significantly across groups. The liner wear group exhibited the highest monocyte proportion of any etiology, at 51.5 percent. Post-hoc testing using the Games-Howell method showed that monocyte percentage in the liner wear group was significantly higher than in the aseptic loosening, instability and arthrofibrosis groups, while lymphocyte percentage was significantly lower than in the arthrofibrosis, aseptic loosening and instability cohorts, with correspondingly lower lymphocyte-to-monocyte and polymorphonuclear-to-monocyte ratios.

The authors interpret this pattern as biologically plausible. Histological research has long demonstrated that polyethylene particulate debris stimulates a targeted, monocyte- and macrophage-driven inflammatory cascade within the joint space, and earlier work by Schwarzkopf and colleagues documented a highly monocyte-predominant synovial fluid differential in patients with wear debris synovitis. By explicitly stratifying tibial liner wear as an independent diagnostic group and evaluating the full differential rather than only total white cell counts and polymorphonuclear percentages, the study captured a shift in the macrophage population that previous analyses, which tended to group wear-mediated failures into broader categories such as aseptic loosening, had overlooked. The finding suggests that wear-mediated failure may generate a distinct localized biological response, a monocyte-predominant and lymphocyte-depleted profile absent in purely mechanical modes of failure.

Yet the researchers are emphatic that this signal cannot yet be treated as a diagnostic tool. With only four patients in the liner wear group, the finding is hypothesis-generating, and the study was not designed to evaluate the diagnostic accuracy of synovial monocyte percentages or to establish a threshold for identifying liner wear. A post-hoc power analysis showed the overall cohort achieved 86 percent statistical power to detect a medium effect size, but the subgroup imbalances gutted the power of the pairwise comparisons involving liner wear and component malposition. The limitations extend further. Excluding patients without preoperative aspirations left a final cohort representing roughly 10 percent of the initial query, introducing selection bias, since aspirated patients inherently carry higher diagnostic uncertainty or clinical suspicion for infection. The twelve-year collection window raises the possibility that changes in techniques and technologies affected the presentation of patients over time, and the retrospective chart review could not confirm whether synovial fluid analysis was performed by automated counting or manual microscopy, a distinction that matters given the artifactual elevation risk in the liner wear subgroup.

The practical takeaway for clinicians is a rebalancing of expectations rather than a new test. Preoperative ESR and CRP remain, in the authors’ words, a non-negotiable step to rule out periprosthetic joint infection, but systemic serology cannot discriminate between specific mechanisms of aseptic failure, and minor elevations should prompt a search for systemic confounders rather than a specific mechanical diagnosis. Standard clinical and radiographic examinations remain the primary methods for determining why an aseptic knee replacement has failed. What the study offers is a clearly stated hypothesis for the next generation of research: that the synovial fluid differential, particularly the monocyte fraction, might eventually help identify polyethylene wear as the culprit before the joint is opened. Larger, prospective studies with standardized synovial fluid collection protocols will be needed to determine whether the monocyte-predominant profile seen in this small subgroup is reproducible and whether it carries any real diagnostic value in distinguishing liner wear from the other causes of aseptic revision.

Subject of Research: Serological and synovial fluid markers across causes of aseptic revision total knee arthroplasty

Article Title: Analysis of serological markers and synovial fluid cytology in aseptic revision total knee arthroplasty

Article References: Khury, F., Zhong, J., Ruff, G., Sarfraz, A., Bahlouli, L., Aggarwal, V. K., & Schwarzkopf, R. (2026). Analysis of serological markers and synovial fluid cytology in aseptic revision total knee arthroplasty. Archives of Orthopaedic and Trauma Surgery, 146(1), Article 374. https://doi.org/10.1007/s00402-026-06536-5

Image Credits: AI Generated

DOI: 10.1007/s00402-026-06536-5

Keywords: total knee arthroplasty, revision surgery, aseptic loosening, liner wear, synovial fluid, ESR, CRP, monocytes, periprosthetic joint infection, arthrofibrosis, instability, orthopedic surgery